Comparison of different methods for the isolation

of mesenchymal stem cells from human

umbilical cord Wharton’s jelly by Salehinejad, Parvin et al.
1 23
In Vitro Cellular & Developmental
Biology - Animal
 
ISSN 1071-2690
Volume 48
Number 2
 
In Vitro Cell.Dev.Biol.-Animal (2012)
48:75-83
DOI 10.1007/s11626-011-9480-x
Comparison of different methods for the
isolation of mesenchymal stem cells from
human umbilical cord Wharton’s jelly
Parvin Salehinejad, Noorjahan Banu
Alitheen, Abdul Manaf Ali, Abdul
Rahman Omar, Maryam Mohit, Ehsan
Janzamin, Fazel Sahraneshin Samani, et
al.
1 23
Your article is protected by copyright and all
rights are held exclusively by The Society for
In Vitro Biology. This e-offprint is for personal
use only and shall not be self-archived in
electronic repositories. If you wish to self-
archive your work, please use the accepted
author’s version for posting to your own
website or your institution’s repository. You
may further deposit the accepted author’s
version on a funder’s repository at a funder’s
request, provided it is not made publicly
available until 12 months after publication.
Comparison of different methods for the isolation
of mesenchymal stem cells from human
umbilical cord Wharton’s jelly
Parvin Salehinejad & Noorjahan Banu Alitheen &
Abdul Manaf Ali & Abdul Rahman Omar &
Maryam Mohit & Ehsan Janzamin &
Fazel Sahraneshin Samani & Zahra Torshizi &
Seyed Noureddin Nematollahi-Mahani
Received: 5 September 2011 /Accepted: 23 December 2011 /Published online: 25 January 2012 / Editor: T. Okamoto
# The Society for In Vitro Biology 2012
Abstract Several techniques have been devised for the
dissociation of tissues for primary culture. These techniques
can affect the quantity and quality of the isolated cells. The aim
of our study was to develop the most appropriate method for
the isolation of human umbilical cord-derived mesenchymal
(hUCM) cells. In the present study, we compared four methods
for the isolation of hUCM cells: three enzymatic methods;
collagenase/hyaluronidase/trypsin (CHT), collagenase/trypsin
(CT) and trypsin (Trp), and an explant culture (Exp) method.
The trypan blue dye exclusion test, the water-soluble tetrazo-
lium salt-1 (WST-1) assay, flow cytometry, alkaline phospha-
tase activity and histochemical staining were used to evaluate
the results of the different methods. The hUCM cells were
successfully isolated by all methods but the isolation method
used profoundly altered the cell number and proliferation
capacity of the isolated cells. The cells were successfully
differentiated into adipogenic and osteogenic lineages and
alkaline phosphatase activity was detected in the hUCM cell
colonies of all groups. Flow cytometry analysis revealed that
CD44, CD73, CD90 and CD105 were expressed in all groups,
while CD34 and CD45 were not expressed. The expression of
C-kit in the enzymatic groups was higher than in the explant
group, while the expression of Oct-4 was higher in the CT
group compared to the other groups. We concluded that the
collagenase/trypsin method of cell isolation yields a higher cell
density than the others. These cells expressed a higher rate of
pluripotent cell markers such as C-kit and Oct-4, while the
explant method of cell isolation resulted in a higher cell pro-
liferation rate and activity compared to the other methods.
Keywords Enzymatic isolation . Explant . Umbilical cord
matrix-derived cells
Introduction
Mesenchymal stem cells (MSC) have been considered as an
appropriate source of cells in the treatment of a number of
congenital and degenerative diseases (Baksh et al. 2004). At
present, bone marrow is the main, traditional source of
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MSCs (Romanov et al. 2003; Zhang et al. 2004; Qiao et al.
2008). However, collection of MSCs from bone marrow is
an invasive and painful procedure (Logeart-Avramoglou et
al. 2005). Also, the number of bone marrow MSCs signif-
icantly decreases with age and infirmity (Rao and Mattson
2001; Bobis et al. 2006). Furthermore, there is a potential
risk of viral contamination during the isolation of MSCs
from bone marrow (Romanov et al. 2003; Kadivar et al.
2005). All these factors limit the use of bone marrow as a
suitable source of MSCs for cell therapy. Therefore, atten-
tion should be focused on tissues containing cells with a
higher proliferative and differentiation potency and a lower
risk of viral contamination. In this regard, Wharton’s Jelly
(Petsa et al. 2009) has been shown to be a suitable source of
MSCs with practical advantages. It is demonstrated that
cells derived from Wharton’s jelly (WJ) of the umbilical
cord, the so-called umbilical cord matrix cells (UCMCs),
have similar characteristics to MSCs (Conconi et al. 2006;
Lu et al. 2006). The UCMCs have surface markers (Weiss et
al. 2006), immune properties (Sotiropoulou et al. 2006) and
a differentiation potential similar to MSCs derived from
bone marrow (Lu et al. 2006). These cells are also more
similar to foetal MSCs in terms of their in vitro expansion
capability (Sotiropoulou et al. 2006). Studies have shown
that hUCMs have the potential of in vitro and in vivo
differentiation into many cell types, including neurons, car-
diomyocytes, striated muscle, insulin secreting cells, carti-
lage and osteocytes (Aghaee-Afshar et al. 2009; Ishige et al.
2009; Leeb et al. 2009; Latifpour et al. 2011). However, up
until now, the question of which was the optimal method for
efficiently isolating MSCs from umbilical cords (UC)
remained unanswered.
The diverse nature of tissue architecture requires different
techniques for cell dispersal; for example, bone, the brain,
skeletal muscle, the liver and the spleen all have different cell–
cell and cell–extracellular matrix associations. A consequence
of this is that no single protocol will serve for all tissue types.
One of the earliest techniques in cell isolation and in vitro cell
propagation is the explant of tissue fragments. This technique
is characterized by reducing the tissue size small enough for
gases and nutrients to diffuse freely (Atala and Lanza 2002).
Success in the primary explanted culture is dependent on the
migratory ability of the type of cells (Saward and Zahradka
1997).
Another common technique is the use of defined enzyme
systems to dissociate of different tissues. The type of en-
zyme employed has an effect on digestion outcome in terms
of efficiency, yield, viability and toxicity (Costa et al. 1987;
Konig et al. 1993). Commercial collagenases from Clostrid-
ium histolyticum are often used in tissue digestion (Williams
et al. 1995; Bowman et al. 1999). In addition, trypsin, with
or without ethylene tetra acetic acid (EDTA), is increasingly
used as a common dissociative enzyme (Freshney 2005).
The duration of the enzymatic treatment is critically impor-
tant, as it may degrade the extracellular matrix and cell mem-
brane, and prevents the cells from adhering to the culture
substrate after isolation (Can and Karahuseyinoglu 2007), so
the enzymatic treatment time should be kept to a minimum.
Taking into consideration the lack of a comparative study
showing the influence of different isolation methods of
hUCMs on cell quantity and quality, in this studywe attempted
to compare various isolation conditions in order to identify the
optimal protocol for hUCM isolation while still maintaining
their growth capacities.
Materials and Methods
Isolation of human umbilical cord matrix-derived mesen-
chymal cells. All materials were purchased from Sigma
Company (Sigma-Aldrich, MO) unless stated otherwise.
Ethical approval was obtained from the Institutional ethical
review board (approval number 69-1780) at Kerman Univer-
sity of Medical Sciences, Kerman, Iran. UC were obtained
from patients who delivered full-term infants by Caesarean
section after written consent was obtained (n015). These
patients faced no complications throughout pregnancy.
Fifteen-centimetre-long cords were immersed in sterile
Hanks’ balanced salt solution, at 4°C, supplemented with
penicillin (300 units/ml), streptomycin (300 μg/ml) and
amphotericin B (7.5 μg/ml), and immediately transferred to
the laboratory. The surface of each cord was rinsed with
phosphate buffered saline (PBS) to remove as much blood
as possible. The cord was cut into 3–5-cm-long pieces using a
sharp, sterile blade. Blood vessels were removed from each
piece after incising the cord lengthwise and the WJ was
carefully separated from the amniotic membrane. The WJ
was cut into small fragments with sharp scissors and scalpels.
The fragments were weighed using a digital weighing ma-
chine and divided into four equal parts among four experi-
mental groups as follows: explant (Exp), collagenase/trypsin
(CT), collagenase/hyaluronidase/trypsin (CHT) and trypsin/
EDTA (Trp) groups.
In the Exp group, pieces with an approximate diameter of
2 mm were seeded onto the surface of a culture dish with
DMEM-F12 supplemented with 10% (v/v) foetal bovine serum
(FBS), penicillin (100 units/ml), streptomycin (100 μg/ml) and
amphotericin B (2.5μg/ml) for 2 wk.Within this period, half of
the culture medium was refreshed every 5 d until the cells
migrated from the fragment borders and reached approximately
80% confluence.
In enzymatic groups, different dosages and time were
examined to obtain the most appropriate dosages and time
(Fig. 1). We kept the time of exposure to the enzymes at
minimum. Thus, in the CT and CHT groups, we added either
1 mg/ml collagenase type B for 3 h or a cocktail consisting of
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1 mg/ml collagenase and 300 μg/ml hyaluronidase to the
tissues for 2 h at 37°C. These tissues were then washed with
PBS and 0.25 mg/ml was added for 15 min at 37°C with
agitation. In the Trp group, the tissue fragments were treated
with 2.5 and 0.2 mg/ml EDTA for 30 min at 37°C with
agitation. The isolated cells were washed with PBS and the
cell pellet was resuspended in the culture medium. The cells
were cultured in 25 cm2 tissue culture flasks and incubated in
a 37°C humid atmosphere with 5% CO2 in the air.
Detection of cell viability. The trypan blue assay was per-
formed on enzymatically isolated cells before the cells were
cultured in the culture medium. A total cell count was accom-
plished using a haemocytometer chamber after staining the
cells with 0.4% trypan blue. The cells that were not stained
with trypan blue were considered viable cells.
Detection of cell proliferation. In order to detect cell growth
rate in the various groups, we calculated the period of time
from seeding the fragments (Exp group) or the onset of cell
culture of the cells in the enzymatic groups until cell conflu-
ence was reached ≤80%.
In order to detect the propagation potential of the isolated
cells, WST-1 assay was used for living cells after the fourth
passage of hUCMCs. It is an ELISA-based one-step method
that determines mitochondrial respiration (Nematollahi-Mahani
et al. 2007). One-hundred-microliter cell suspensions
(1×104 cells/ml) were introduced to each well of a 96-well
plate and incubated at 37°C for 48 h. At the end of the
incubation period, 10 μl of WST-1 solution was added to each
well. After 1 h incubation at 37°C the absorbance was mea-
sured at a 450 nm wavelength and reference wavelengths of
630 nm with an ELISA reader (Bioteck, IA).
Flow cytometry. Cells were prepared at a concentration of
1×105 cells/ml in DMEM/LG with 10% FBS. The cells
were washed, fixed and permeabilized with 0.2% Triton
X-100 (Oct-4 only) and incubated for 15 min at 4°C with a
1:9 dilution of normal goat serum in PBS to block non-specific
binding of the primary antibody. The cells were then labelled
with the following antibodies: FITC-conjugated anti-CD44,
FITC-conjugated anti-CD34 (Chemicon, IL), FITC-
conjugated anti-CD45 (eBioscience, USA), PE-conjugated-
anti-CD73 (Becton Dickinson [BD], NJ), PE-conjugated anti-
CD90 (Dako, Denmark) and PE-conjugated anti-CD105
(R&D Systems, MN) for 1 h. Mouse primary antibodies and
FITC-conjugated anti-CD117 and FITC-conjugated anti-Oct-4
were labelled for 45 min followed by goat anti-mouse IgG for
CD117 and goat anti-rat IgG for Oct-4 (R&D Systems, MN).
The cells were washedwith 2%FBS in PBS and analysed using
a FACSCalibur (BD, NJ) machine. The control population was
stained with matched isotype antibodies (FITC- and PE-
conjugated mouse IgG monoclonal isotype standards), which
were confirmed by positive fluorescence of the limbal samples.
At least 10,000 events were recorded for each sample and data
were analysed using WinMDI software (BD Biosciences).
Alkaline phosphatase activity. The hUCM cells from the
fourth passage were grown on clean, sterile glass slides for 2–
3 wk. The medium was refreshed every 5 d. Alkaline phospha-
tase activity was detected using an ALP Kit (R-87 Sigma)
according to the manufacturer’s instructions. A dark red prod-
uct after 20 min exposure to the substrate confirmed ALP
activity. The cells were then counterstained with haematoxylin
and mounted and photographed using an Olympus DP71 dig-
ital camera attached to an IX71 inverted microscope (Japan).
Induction of adipogenic and osteogenic differentiation. The
hUCM cells (5×103 cells/cm2) were seeded on 3 cm plates in
DMEM-F12 supplemented with 10% FBS for 2 d. Osteogenic
Figure 1. The appropriate duration of the enzymatic treatment on
human umbilical cord was assessed in a preliminary study. (A) 1 mg/ml
collagenase for 3 h; (B) 300 μg/ml hyaluronidase for 120 min and (C )
2.5 mg/ml trypsin for 30 min resulted in a higher number of hUCMs.
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and adipogenic differentiationmedia were then added for 2 and
3 wk for adipogenic and osteogenic differentiation, respective-
ly. The adipogenic differentiation medium was composed of
DMEM-F12 supplemented with 10%FBS, 100 nM dexameth-
asone, 50 μg/ml ascorbic acid and 50 μg/ml indomethacin.
The osteogenic differentiation medium contained DMEM-F12
supplemented with 10% FBS, 10 nM dexamethasone, 10 mM
β-glycerophosphate and 50 μg/ml ascorbic acid. As a negative
control, cells were cultured in a proliferative medium deprived
of the differentiation factors. Adipogenic differentiation was
detected byOil Red O staining while osteogenic differentiation
was detected by Alizarin Red-S staining.
Statistical analysis. Data from the different tests were
expressed as mean±SE and were analysed by one-way
ANOVA followed by post hoc Tukey’s test, after normality
assumption; p<0.05 was considered statistically significant.
Results
Cell number. The initial cell number was 0.5–1×104 cells
per cm of UC in CT, 0.25×104 cells per cm of UC in CHT, and
1×103 cells per cm of UC in the Trp groups. The number of
isolated cells was 1×105, 0.5×105 and 0.5×104 cells per gram
of WJ in the CT, CHT and Trp groups, respectively.
Cell morphology. The primary isolated cells had a heteroge-
neous shape, including fibroblast-like cells with short and long
processes and small round cells with a relatively high nuclear to
cytoplasm ratio, as well as flat cells, in the CTand CHT groups
Fig. 2a, b. However, in the Trp Fig. 2c and Exp groups Fig. 2d,
the isolated cell populations were less heterogeneous; with
fibroblast-like cells which being predominant.
Cell proliferation. The interval between the primary culture
and the first passage was approximately 4 wk in the Exp,
10 d in the CT, and 20 d in the CHT groups. In the Trp
group, the cells did not continue to proliferate at a noticeable
rate after 30 d in the culture.
The level of cell viability and proliferation was different in
the different groups. In the Exp group, cell proliferation was
significantly higher (p<0.001) than in the other groups. Also,
the cells isolated by collagenase/trypsin digestion had a signif-
icantly higher (p<0.05) proliferation rate compared to the CHT
group (Fig. 3).
Flow cytometry. The isolated cells in all groups were negative
for the haematopoietic cells surface markers CD34 and CD45.
Cells from all groups were positive against mesenchymal stem
cell markers CD44 and CD105 with similar expression inten-
sities. However, the mesenchymal stem cell markers CD73 and
CD90 were expressed differently in the different groups
(Fig. 4). The cells isolated by the CTand Exp methods showed
Figure 2. Morphological features of the isolated cells derived from
human umbilical cord Wharton’s jelly in three enzymatic groups on the
second day of isolation and in explant group (d ) at the third wk of
isolation. (a) Three types of isolated cells (fibroblast-like cells possess-
ing short and long processes, arrow; and flat cells, short arrow; as well
as small round cells, arrowhead) in the collagenase/trypsin group. Note
that the cell population was much greater in this group than the other
groups. (b) Three types of cells isolated in the collagenase/hyaluroni-
dase/trypsin group. (c) Spindle-shaped cells (arrows) in the trypsin and
(d ) explant groups. Magnification, ×200 in collagenase/trypsin, colla-
genase/hyaluronidase/trypsin and trypsin groups and ×100 in the ex-
plant group.
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higher expression rates of CD90 (72.23±3.64 and 55.79±5.95,
respectively) than CHT group (28.53±1.81). Furthermore,
CD73 was expressed higher rate in the Exp group (74.47±
0.67) than the CHT group (13.33±5.02). Both the CTand CHT
populations expressed a considerable level of C-kit (33.05±
8.41 and 42.14±27.67, respectively) compared to 4.56±0.79 in
the Exp population. Cells in the Exp and CHT groups slightly
expressed Oct-4 (11.31±1.77 and 6.08±3.64, respectively)
compared to 30.66±7.55 in the CT group (Table 1).
Alkaline phosphatase activity. The colonies formed by the
hUCM cells exhibited ALP activity, which is consistent with
the stem cell identity. The hUCM cells were maintained in
culture until colony formation was observed. The reaction
product was most intense within and surrounding the colonies.
Also, ALP activity was observed in a small number of single
cells in all groups Fig. 5a,b,c. There was no significant differ-
ence in ALP activity between the groups (p>0.05).
Adipogenic and osteogenic differentiation. In this study, an
accumulation of lipid-containing vacuoles was detected in all
groups as early as 6–7 d after the onset of treatment. Adipocytes
began to morphologically appear, and their numbers increased
with time. At day 15, approximately 15–20% of the cells
appeared to be adipocytes, as determined by Oil Red O staining
Fig. 6a,b,c. Osteogenic activity was observed on day 21 of
treatment Fig. 6d,e,f. Human bone tissue was stained as the
positive control by Alizarin Red-S Fig. 6h. No Oil Red O or
Alizarin Red-S-positive cells were detected in the control group
Figure 3. Cell proliferation was assessed by the WST-1 method. The
highest proliferation rate was found in the Exp (explant) group followed
by the CT (collagenase/trypsin) and CHT (collagenase/hyaluronidase/
trypsin) groups.
Figure 4. Representative of flow cytometry results. Data were
obtained from passage 4. The black histograms show the isotype
control-stained cells and the red histograms show the antibody-
stained cells. The control population was stained with matched isotype
antibodies (FITC-conjugated and PE-conjugated mouse IgG1κ mono-
clonal isotype standards), which were confirmed by positive fluores-
cence of the limbal samples.
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Fig. 6g. The effects of the isolation methods on adipogenic and
osteogenic differentiation were not significant (p>0.05).
Discussion
The techniques for the separation of adult stem cells from
tissues and foetal mesenchymal stem cells from foetal mem-
branes and tissues need to be refined, since the separation from
stromal-contaminating components has not been optimized
(Lorenzini et al. 2008). The isolation protocols allow cells to
be reproducibly isolated and retain their morphological and
phenotypical features throughout passage (La Rocca et al.
2009). However, no single isolation method has still been
introduced as a standard protocol. Thus, we investigated
whether or not isolation methods can affect cell characteristics.
We found that the utilization of collagenase/trypsin enzymes
gives better results than the other isolation methods (i.e. colla-
genase/hyaluronidase/trypsin, trypsin and explant). We also
found that the fibroblast-like cell populations obtained in this
study have similar properties in regard to morphology, immu-
nophenotype and differentiation potential with MSCs.
The impacts of different enzymes on the morphology of
isolated cells have shown some differences. In our study, the
trypsin cell isolation protocol yielded cells with a different
morphology compared to the cells in the other groups. It was
shown that trypsin-dispersed cells consist of comparatively
smaller cells, whereas collagenase-dispersed cells consist of
larger cells (Miyazaki et al. 1984). Our results showed that the
cells obtained via the trypsin method had a thin spindle-
shaped morphology whereas the cells obtained by the other
enzymatic methods had thick spindle, small round and flat
shapes. In addition, the cells in the Trp group did not prolif-
erate as fast as the cells in the other groups. This issue was so
severe it prevented further assays being performed on these
cells. We suggest that degradation of the extracellular matrix
and disintegration of cell membranes may have caused cellu-
lar damage through the use of trypsin alone for a long period
(Freshney 2005), because some cells are sensitive to exposure
with trypsin but not to collagenase (Oyama et al. 1990).
Cell isolation using trypsin followed by digestion of the
remaining tissue with collagenase proved to be very effective
for obtaining MSCs (Semenov et al. 2009). Trypsin converts
pro-collagenase into the active form of the enzyme (Stricklin et
al. 1977), somost of the connective tissue cells will be released.
Also, light trypsinization after using collagenase removes all
adherent cells except macrophages (Freshney 2005). We used
trypsin after collagenase or collagenase/hyaluronidase to pro-
mote the quantity and quality of the isolated cells.
The lack of a standard method for isolating WJ cells orig-
inates from the differences between the markers used to char-
acterize suchmesenchymal cells. CD73, CD105 and CD44 are
just a few of the numerous markers shown to be present on
MSCs (Schugar et al. 2009). It has been reported that differ-
ences in isolation and subculture protocols may lead to differ-
ent cell lines in terms of both gene expression and stemness
potencies (La Rocca et al. 2009). Many of the markers men-
tioned vary in their expression due to variations in tissue
source, the methods of isolation and culture and species differ-
ences (Chamberlain et al. 2007). Interestingly, some antigens
can be found on freshly isolated MSCs, but their expression
disappears in culture (Bobis et al. 2006). It is important to note
that differences in the expression of many cell surface markers
can be influenced by factors secreted by accessory cells in the
initial passage (Chamberlain et al. 2007). We found some
differences between the different groups when the pattern of
surface marker expression was considered. Expression of the
haematopoietic markers CD34 and CD45, and the mesenchy-
mal stem cell markers CD44 and CD105, was almost similar in
all groups. However, the expression of mesenchymal markers
CD73 and CD90 were different among the three groups. The
results reported by other investigators are inconsistent to some
Table 1. Flow cytometry results for the CT, CHT and EXP groups
Intracellular or
surface antigens
CT group EXP group CHT group
CD 34 5.79±0.21 5.40±2.57 13.61±3.22
CD 45 7.08±1.85 10.38±0.08 15.84±0.58
CD 44 97.69±0.94 93.01±7.92 93.54±0.92
CD 73 67.32±3.28 74.47±0.67 13.33±5.02
CD 90 72.23±3.64 55.79±5.95 28.53±1.81
CD 105 90.30±8.16 83.06±2.73 74.19±0.19
C-Kit 33.05±8.41 4.56±0.79 42.14±27.67
OCT4 30.66±7.55 11.31±1.77 6.08±3.64
The values are mean±SD percentage of cells expressing each antigen
and were derived from three independent experiments
Figure 5. The cell colonies
positively stained with alkaline
phosphatase (red colour) in the
(a) collagenase/trypsin group,
(b) collagenase/hyaluronidase/
trypsin group and
(c) explant group. Original
magnification ×200.
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degree when cell marker expression is considered. For Exam-
ple expression patterns for CD105, CD73, CD44 and CD90
were reported to be 35%, 42%, 48% and 65%, respectively, on
WJ cells following isolation by collagenase digestion (Schugar
et al. 2009), whereas, 96% and 91% of the hUCM cells stained
positively for CD44 and CD90, respectively. These cells were
harvested by an enzyme cocktail (e.g., hyaluronidase, trypsin
and collagenase; Weiss et al. 2006). More comparisons are
necessary in order to explain the reasons for these differences.
It is certain that the collagenase digestion process will consis-
tently isolate a specific cell population expressing MSC sur-
face markers when compared to the dispase digestion and
mechanical dissociation/explant culture methods (Schugar et
al. 2009). Expression of Oct-4 and C-kit was also dissimilar
between the groups. These two markers had a greater level of
expression in the CT and CHT groups compared to the Exp
group. Stromal cells, as the dominant cells in foetal-derived
tissue, possess multipotent properties and are located between
embryonic stem cells and adult stem cells (Can and Karahu-
seyinoglu 2007). Whereas they share common surface
markers with bone marrow-derived MSCs, they also express
certain embryonic stem cell markers, albeit at low levels, such
as Oct-4 (Kadam et al. 2009; Huang et al. 2010a, b), C-kit
(Vawda 2008) and Nanog, both at the mRNA and protein
levels (Can and Karahuseyinoglu 2007; Nematollahi-Mahani
et al. 2008). It is possible that MSCs fromWJ are earlier-stage
cells, the so-called more primary cells, than the MSCs of adult
bone marrow (Wang et al. 2004).
Isolation protocols may also alter epigenetic and genetic
changes in the cells, which may dramatically affect their plas-
ticity and therapeutic utility (Phinney and Prockop 2007).
Marked morphological and cell-size differences have been
observed in the UC-derived primary cultures. The small-
sized subpopulation exhibited a higher proliferative capacity
compared to the total UC-derived primary cultures and the
large-sized cells (Majore et al. 2009). Cell activity determined
by the WST-1 assay showed that the cell proliferation rate was
highest in the Exp group, followed by CT and then CHT
groups. We suggest that the more homogeneous morphology
of the cells in the Exp group might have resulted in the highest
cell proliferation in this group. Also, damage to the extracel-
lular matrix and cell membranes during enzymatic dissociation
could have had an impact on the lower proliferation capacity of
the CT and CHT cells.
The proportion of ALP-positive cells was highest in the CT
group, followed by the Exp and CHT groups. The isolation
procedure (explant versus enzyme treatment) apparently influ-
ences ALP levels at the start of osteoblast subcultures, where
ALP activity was found to be higher in the enzymatic method
compared to the explant method (Declercq et al. 2004). Our
results are in accordancewith the results of Schugar et al. (2009),
who detected an increased presence of ALP in collagenase-
isolated cells. Also, like the results of previously reported stud-
ies, the results of the present study show that the reaction product
of alkaline phosphatase was most intense at the margins of the
colonies, and a positive reaction was observed in some of the
individual cells (Nematollahi-Mahani et al. 2008) in all groups.
We cultured hUCM cells for 21 d in adipogenic medium
and then evaluated them by Oil Red staining. However,
Karahuseyinoglu et al. (2007) reported that hUCM cells were
shown adipocyte phenotype in 40 d. Our results were also
similar to Struys et al. (2011) results that only less than one
third of the hMSCs had adipogenic potential. Moreover, in our
results the osteogenic differentiation of mesenchymal cells
derived from Wharton’s jelly was achieved after 28 d of
culture that this time has been also noted by Karahuseyinoglu
et al. (2007). In any case, whether or not isolation methods
including the proper time of incubation can affect the
Figure 6. Adipogenic differentiation in the (a) collagenase/trypsin, (b)
collagenase/hyaluronidase/trypsin and (c) explant groups. Oil Red-
positive adipocytes stained bright orange. Osteogenic differentiation in
the (d ) collagenase/trypsin, (e) collagenase/hyaluronidase/trypsin and (f )
explant groups. Alizarin Red-S-positive calcium deposition appeared as a
red precipitate. (g) No Oil Red O or Alizarin Red-S-positive cells were
detected in the control group. (h) Human bone tissue stained as a positive
control by Alizarin Red-S. Original magnification ×100.
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differentiation potential of these cells into other cell lineages
needs to be investigated.
Conclusions
The purpose of this investigation was to develop the most
appropriate method for isolating hUCMs. Isolation methods
have a significant influence on the purity and growth capacity
of isolated mesenchymal cell populations. When collagenase/
trypsin enzymes are used, the waiting time for primary culture
is shorter and results in (a) a higher number of isolated cells
and (b) greater pluripotency properties of the isolated cells.
The utilization of collagenase/trypsin enzymes is superior to
the other isolation methods when the isolation and harvest of
mesenchymal cells from humanWharton’s jelly is considered.
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